Skip to content
Back to RARE

Ultragenyx Pharmaceutical Inc.

Open-market purchases and sales reported on SEC Forms 4 and 5, with each filing and its footnotes.

Since Nov 18, 2025
Transactions
28
Purchases
0
Sales
28
Purchase value
$0.00
Sale value
$3.81M

Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.

Howard HornChief Financial Officer
4
Filed Oct 19, 2026Period of report Oct 15, 20260001193125-26-425032
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleOct 15, 2026
Common StockF1F27,066$15.27$107.90K89,229Direct
Filing footnotes · 2
  1. F1Represents shares sold to pay required tax withholdings due to the vesting of RSUs.
  2. F2Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.
Open on SEC EDGAR
Theodore Alan HuizengaSVP, Chief Accounting Officer
4Rule 10b5-1 plan disclosed
Filed Sep 15, 2026Period of report Sep 15, 20260001193125-26-392233
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleSep 15, 2026
Common StockF11,283$13.57$17.41K67,863Direct
Filing footnotes · 1
  1. F1Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.
Open on SEC EDGAR
Theodore Alan HuizengaSVP, Chief Accounting Officer
4
Filed Sep 8, 2026Period of report Sep 3, 20260001193125-26-384878
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleSep 3, 2026
Common StockF1F2F3161$13.99$2.25K69,146Direct
Filing footnotes · 3
  1. F1Represents shares sold to pay required tax withholdings due to the vesting of RSUs.
  2. F2Includes 396 shares acquired under the Company's Amended and Restated Employee Stock Purchase Place on April 30, 2026.
  3. F3Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.
Open on SEC EDGAR
Karah Herdman ParschauerEVP and Chief Legal Officer
4Rule 10b5-1 plan disclosed
Filed Aug 4, 2026Period of report Aug 3, 20260001193125-26-332547
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleAug 3, 2026
Common StockF11,900$24.92$47.35K92,562Direct
Filing footnotes · 1
  1. F1Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.
Open on SEC EDGAR
Howard HornChief Financial Officer
4Rule 10b5-1 plan disclosed
Filed Aug 4, 2026Period of report Aug 3, 20260001193125-26-332536
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleAug 3, 2026
Common StockF14,696$24.92$117.02K96,295Direct
Filing footnotes · 1
  1. F1Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.
Open on SEC EDGAR
Howard HornChief Financial Officer
4Rule 10b5-1 plan disclosed
Filed Jul 6, 2026Period of report Jul 1, 20260001193125-26-296128
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJul 1, 2026
Common StockF14,698$33.13$155.64K100,991Direct
Filing footnotes · 1
  1. F1Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.
Open on SEC EDGAR
Corazon (Corsee) D. SandersDirector
4
Filed Jun 15, 2026Period of report Jun 15, 20260001796536-26-000007
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJun 15, 2026
Common StockF12,000$25.05$50.10K21,095Direct
Filing footnotes · 1
  1. F1Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.
Open on SEC EDGAR
Karah Herdman ParschauerEVP and Chief Legal Officer
4Rule 10b5-1 plan disclosed
Filed Jun 15, 2026Period of report Jun 15, 20260001677455-26-000002
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJun 15, 2026
Common StockF1F21,899$24.62$46.75K94,462Direct
Filing footnotes · 2
  1. F1Includes 646 shares acquired under the Company's Amended and Restated Employee Stock Purchase Place on April 30, 2026
  2. F2Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.
Open on SEC EDGAR
Howard HornChief Financial Officer
4Rule 10b5-1 plan disclosed
Filed Jun 1, 2026Period of report Jun 1, 20260001786335-26-000002
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJun 1, 2026
Common StockF14,653$23.77$110.60K105,689Direct
Filing footnotes · 1
  1. F1Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.
Open on SEC EDGAR
Shehnaaz SulimanDirector
4Rule 10b5-1 plan disclosed
Filed May 18, 2026Period of report May 14, 20260001713070-26-000002
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMay 18, 2026
Common Stock5,740$25.12$144.19K27,951Direct
Filing footnotes · 2
  1. F1Award of Restricted Stock Units ("RSUs") under the Company's 2023 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) May 14, 2027.
  2. F2The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) May 14, 2027.
Open on SEC EDGAR
Eric CrombezEVP and Chief Medical Officer
4
Filed May 6, 2026Period of report May 5, 20260001193125-26-208632
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMay 5, 2026
Common StockF1F2F3344$24.96$8.59K111,189Direct
Filing footnotes · 3
  1. F1Represents shares sold to pay required tax withholdings due to the vesting of RSUs.
  2. F2Includes 558 shares acquired under the Company's Amended and Restated Employee Stock Purchase Plan on April 30, 2026
  3. F3Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.
Open on SEC EDGAR
Howard HornChief Financial Officer
4Rule 10b5-1 plan disclosed
Filed May 4, 2026Period of report May 1, 20260001193125-26-204402
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMay 1, 2026
Common StockF14,683$24.90$116.61K110,342Direct
Filing footnotes · 1
  1. F1Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.
Open on SEC EDGAR
Howard HornChief Financial Officer
4Rule 10b5-1 plan disclosed
Filed Apr 2, 2026Period of report Apr 1, 20260001193125-26-140702
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleApr 1, 2026
Common StockF14,683$20.97$98.20K80,351Direct
Filing footnotes · 1
  1. F1Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.
Open on SEC EDGAR
Karah Herdman ParschauerEVP and Chief Legal Officer
4
Filed Mar 10, 2026Period of report Mar 6, 20260001193125-26-100309
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMar 10, 2026
Common StockF13,508$22.67$79.53K66,820Direct
SaleMar 6, 2026
Common Stock6,018$21.40$128.79K70,328Direct
Filing footnotes · 1
  1. F1Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.
Open on SEC EDGAR
Howard HornChief Financial Officer
4Rule 10b5-1 plan disclosed
Filed Mar 3, 2026Period of report Mar 1, 20260001193125-26-089107
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMar 3, 2026
Common StockF41,635$22.40$36.62K85,034Direct
SaleMar 2, 2026
Common StockF2F35,290$22.80$120.61K89,788Direct
SaleMar 2, 2026
Common Stock3,119$22.54$70.30K86,669Direct
Filing footnotes · 4
  1. F1Represents shares of common stock which previously granted performance stock units were converted on March 1, 2026 upon certification of the performance metric.
  2. F2Represents shares sold to pay required tax withholdings due to the vesting of RSUs.
  3. F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.54 to $23.11 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range
  4. F4Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.
Open on SEC EDGAR
John Richard PinionSee Remarks
4
Filed Mar 3, 2026Period of report Mar 1, 20260001193125-26-089287
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMar 2, 2026
Common StockF2F3F4F510,029$22.80$228.66K110,026Direct
Filing footnotes · 5
  1. F1Represents shares of common stock which previously granted performance stock units were converted on March 1, 2026 upon certification of the performance metrics.
  2. F2Represents shares sold to pay required tax withholdings due to the vesting of RSUs.
  3. F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.54 to $23.11 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range
  4. F4Includes 490 shares acquired under the Company's Amended and Restated Employee Stock Purchase Plan on April 30, 2025
  5. F5Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.
Open on SEC EDGAR
Erik HarrisEVP & Chief Commercial Officer
4
Filed Mar 3, 2026Period of report Mar 1, 20260001193125-26-089282
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMar 2, 2026
Common StockF2F3F4F510,539$22.80$240.29K89,515Direct
Filing footnotes · 5
  1. F1Represents shares of common stock which previously granted performance stock units were converted on March 1, 2026 upon certification of the performance metrics.
  2. F2Represents shares sold to pay required tax withholdings due to the vesting of RSUs.
  3. F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.54 to $23.11 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range
  4. F4Includes a total of 556 shares acquired under the Company's Amended and Restated Employee Stock Purchase Plan on April 30, 2025 and October 31, 2025.
  5. F5Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.
Open on SEC EDGAR
Emil D KakkisDirector · President & CEO
4
Filed Mar 3, 2026Period of report Mar 1, 20260001193125-26-089278
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMar 2, 2026
Common StockF2F3F4F554,404$22.80$1.24M658,994Direct
Filing footnotes · 5
  1. F1Represents shares of common stock which previously granted performance stock units were converted on March 1, 2026 upon certification of the performance metrics.
  2. F2Represents shares sold to pay required tax withholdings due to the vesting of RSUs.
  3. F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.54 to $23.11 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range
  4. F4Includes 490 shares acquired under the Company's Amended and Restated Employee Stock Purchase Plan on April 30, 2025.
  5. F5Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.
Open on SEC EDGAR
Karah Herdman ParschauerEVP and Chief Legal Officer
4
Filed Mar 3, 2026Period of report Mar 1, 20260001193125-26-089111
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMar 2, 2026
Common StockF2F3F4F58,135$22.80$185.48K76,346Direct
Filing footnotes · 5
  1. F1Represents shares of common stock which previously granted performance stock units were converted on March 1, 2026 upon certification of the performance metrics.
  2. F2Represents shares sold to pay required tax withholdings due to the vesting of RSUs.
  3. F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.54 to $23.11 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range
  4. F4Includes 73 shares acquired under the Company's Amended and Restated Employee Stock Purchase Plan on October 31, 2025
  5. F5Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.
Open on SEC EDGAR
Theodore Alan HuizengaSVP, Chief Accounting Officer
4
Filed Mar 3, 2026Period of report Mar 2, 20260001193125-26-089109
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMar 2, 2026
Common StockF2F3F41,632$22.80$37.21K48,670Direct
Filing footnotes · 4
  1. F1Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs.
  2. F2Represents shares sold to pay required tax withholdings due to the vesting of RSUs.
  3. F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.54 to $23.11 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range
  4. F4Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.
Open on SEC EDGAR
Eric CrombezEVP and Chief Medical Officer
4
Filed Mar 3, 2026Period of report Mar 1, 20260001193125-26-089104
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMar 2, 2026
Common StockF2F3F4F57,029$22.80$160.26K76,301Direct
Filing footnotes · 5
  1. F1Represents shares of common stock which previously granted performance stock units were converted on March 1, 2026 upon certification of the performance metrics.
  2. F2Represents shares sold to pay required tax withholdings due to the vesting of RSUs.
  3. F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.54 to $23.11 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range
  4. F4Includes 157 shares acquired on October 30, 2025 under the Company's Amended and Restated Employee Stock Purchase Plan
  5. F5Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.
Open on SEC EDGAR
Howard HornChief Financial Officer
4Rule 10b5-1 plan disclosed
Filed Feb 3, 2026Period of report Feb 2, 20260001193125-26-034832
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 2, 2026
Common StockF13,061$23.56$72.12K88,935Direct
Filing footnotes · 1
  1. F1Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.
Open on SEC EDGAR
Howard HornChief Financial Officer
4Rule 10b5-1 plan disclosed
Filed Jan 5, 2026Period of report Jan 2, 20260001193125-26-002410
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJan 2, 2026
Common StockF13,150$22.84$71.95K91,996Direct
Filing footnotes · 1
  1. F1Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.
Open on SEC EDGAR
Theodore Alan HuizengaSVP, Chief Accounting Officer
4
Filed Dec 30, 2025Period of report Dec 29, 20250001193125-25-336619
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleDec 29, 2025
Common StockF1F2F385$34.38$2.92K50,450Direct
Filing footnotes · 3
  1. F1Represents shares sold to pay required tax withholdings due to the vesting of RSUs.
  2. F2Includes 293 shares acquired under the Company's A&R 2014 Employee Stock Purchase Plan on October 31, 2025.
  3. F3Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.
Open on SEC EDGAR
Howard HornChief Financial Officer
4Rule 10b5-1 plan disclosed
Filed Dec 11, 2025Period of report Dec 10, 20250001193125-25-315460
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleDec 10, 2025
Common StockF13,081$36.38$112.09K95,146Direct
Filing footnotes · 1
  1. F1Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.
Open on SEC EDGAR

P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.